The European Hematology Association 26th congress EHA 2021

congress program
Location : Online
Country : Netherlands
Language : ENG
Start :
End :
https://ehaweb.org/congress/eha-congress-2021/key-information/
Specialities : Hematology
ZUMA-3: KTE-X19, an anti-CD19 chimeric antigen receptor T-cell therapy for R/R B-cell

- Date : 2021-06-17
- 1
0
Interim analysis from the OPTIC trial, a dose-ranging study of ponatinib for CP-CML

- Date : 2021-06-17
- 0
0
A comparison of clinical outcomes from ZUMA-5 and the international scholar-5 external control

- Date : 2021-06-17
- 0
0
A phase II study of blinatumomab for the treatment of MRD-positive B-cell acute lymphoblastic

- Date : 2021-06-17
- 0
0
Interim results of a phase II study of blinatumomab plus ponatinib for Philadelphia

- Date : 2021-06-17
- 0
0
Isatuximab, carfilzomib, lenalidomide and dexamethasone (Isa-KRd) in front-line treatment

- Date : 2021-06-17
- 0
0
Once weekly selinexor, carfilzomib, and dexamethasone (XKD)in carfilzomib non-refractory

- Date : 2021-06-17
- 0
0
Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone

- Date : 2021-06-17
- 0
0
Selected conferences
33ème Congrès International de la Society on Thrombosis and Haemostasis - ISTH 2025
- Date : 2025-06-21
-
861 0
Sommet Comprehensive Care de la Fédération Internationale de l'hémophilie – FMH 2025

- Date : 2025-04-23
-
733 0